SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

PartnershipProstate Genomic Instability ScorePositive

AI Analysis

Summary

SOPHiA GENETICS and Myriad Genetics announced a collaboration to advance prostate genomic instability score (PrGIS) technology for precision oncology approaches in partnership with AstraZeneca.

Importance:6/10

Sentiment:

0.60

precision oncologyprostate cancergenomic instabilitycollaborationtechnology advancement

Related Companies

$SOPH $MYGN $AZN

Read the original article

Published by PR Newswire Clinical Trials on October 8, 2026 1:00 PM

Read Original